| Cathryn Mary Crow, AGACNP-BC | |
|
2799 W Grand Blvd, Detroit, MI 48202-2689 | |
| (313) 916-2600 | |
| Not Available |
| Full Name | Cathryn Mary Crow |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 2799 W Grand Blvd, Detroit, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659055945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 4704311340 (Michigan) | Secondary |
| 363L00000X | Nurse Practitioner | 4704311340 (Michigan) | Primary |
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104900455 PECOS PAC ID: 0547178311 Enrollment ID: O20031210000341 |
News Archive
A crippling condition that can result in sufferers losing their fingers is to be investigated by scientists in one of the most detailed studies into the genetic causes of the disease ever carried out.
A team from the International School for Advanced Studies in Trieste has obtained very promising results by applying gene therapy to glioblastoma.
Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.
In an aging society, one of the most important and urgent tasks of scientific research is to counteract the decline in motor function and muscle weakness that accompanies the aging process.
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cathryn Mary Crow, AGACNP-BC 2799 W Grand Blvd, Detroit, MI 48202-2689 Ph: (313) 916-2600 | Cathryn Mary Crow, AGACNP-BC 2799 W Grand Blvd, Detroit, MI 48202-2689 Ph: (313) 916-2600 |
News Archive
A crippling condition that can result in sufferers losing their fingers is to be investigated by scientists in one of the most detailed studies into the genetic causes of the disease ever carried out.
A team from the International School for Advanced Studies in Trieste has obtained very promising results by applying gene therapy to glioblastoma.
Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.
In an aging society, one of the most important and urgent tasks of scientific research is to counteract the decline in motor function and muscle weakness that accompanies the aging process.
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.
› Verified 7 days ago